Data independent acquisition mass spectrometry (DIA-MS) in cancer studies: a concise review.
1/5 보강
Advances in proteomics are reshaping our understanding of cancer biology by enabling the direct quantification of proteins and their modifications in complex biological systems.
APA
Kumar BS (2026). Data independent acquisition mass spectrometry (DIA-MS) in cancer studies: a concise review.. Analytical methods : advancing methods and applications, 18(1), 10-38. https://doi.org/10.1039/d5ay01294e
MLA
Kumar BS. "Data independent acquisition mass spectrometry (DIA-MS) in cancer studies: a concise review.." Analytical methods : advancing methods and applications, vol. 18, no. 1, 2026, pp. 10-38.
PMID
41370111 ↗
Abstract 한글 요약
Advances in proteomics are reshaping our understanding of cancer biology by enabling the direct quantification of proteins and their modifications in complex biological systems. Among emerging mass spectrometry techniques, Data-Independent Acquisition (DIA) has established itself as a transformative approach for cancer proteomics. DIA offers unprecedented depth, reproducibility, and scalability by systematically fragmenting all precursor ions across defined mass ranges, allowing comprehensive proteome coverage and retrospective data analysis. This review highlights the fundamental principles of DIA-MS, recent technological developments-including spectral library-free workflows, and their impact on cancer research. We discuss the application of DIA in tumor classification, biomarker discovery, therapeutic target identification, and treatment response monitoring. Particular attention is given to its compatibility with clinical samples such as formalin-fixed paraffin-embedded (FFPE) tissues and its integration into large-scale efforts like CPTAC. Current challenges with the technique will be explored, including data analysis complexity and standardization, and future directions that could bring DIA-MS closer to clinical utility. DIA-MS is rapidly evolving into a cornerstone technology for precision oncology, with the potential to bridge research and clinical practice through robust, high-resolution proteomic profiling.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.